Showing results (471-480 of 480) with videos related to
Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 480 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.JAMA Oncology|July 2, 2016
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA MutationsCatherine A Shu, Malcolm C Pike, Anjali R Jotwani, et al.Cancer Research|July 30, 2011
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting GenesTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.Cell Stem Cell|June 18, 2013
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristicsSibgat Choudhury, Vanessa Almendro, Vanessa F Merino, et al.Nature Communications|September 15, 2019
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situLina Ding, Ying Su, Anne Fassl, et al.Space Science Reviews|January 30, 2026
Comprehensive Observations of Magnetospheric Particle Acceleration, Sources, and Sinks (COMPASS): A Mission Concept to Explore the Extremes of Jupiter's MagnetosphereGeorge Clark, P Kollmann, J Kinnison, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriersAmanda B Spurdle, Louise Marquart, Lesley McGuffog, et al.American Journal of Human Genetics|March 22, 2008
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Amanda B Spurdle, Olga M Sinilnikova, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.Nature Genetics|September 21, 2010
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationAntonis C Antoniou, Xianshu Wang, Zachary S Fredericksen, et al.Pageof 48